Special Issue "Algal Toxins II, 2017"
A special issue of Marine Drugs (ISSN 1660-3397).
Deadline for manuscript submissions: 31 May 2017
Algae are fundamental components of essentially all aquatic, including both marine and freshwater, systems. Furthermore, both macroalgae (i.e., "seaweeds”) and microalgae—which span several eukaryotic (i.e., protist) and prokaryotic (i.e., cyanobacteria) taxa—are recognized producers of a myriad of bioactive metabolites of growing interest as both potential environmental toxins, and alternatively potential leads to novel drugs. In this regard, bioactive compounds from algae arguably represent “two sides of a coin” whereby understanding their potential as toxins is closely linked, in turn, with understanding their biomedical potential, particularly in relation to possible leads to drugs or related applications. As such, this Special Issue will focus on algal “toxins,” and more generally bioactive metabolites, including interrelated aspects of (1) discovery of new toxic or otherwise bioactive metabolites; (2) innovative toxicological and/or pharmacological approaches to characterize biological activity; (3) advancements in our understanding of the biosynthesis of algal toxins; and (4) development and/or innovative application of analytical techniques aimed at evaluating the contribution of these bioactive molecules as toxins.
Prof. Dr. John P. Berry
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All papers will be peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Marine Drugs is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 1800 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.